Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Abstract Text:

Yu Watanabe,Hiroyuki Kato,Tsutomu Araki,

We examined the effects of 7-nitroindazole on the dopaminergic system in mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. The mice received four intraperitoneal injections of MPTP (20 mg/kg) at 2 h-intervals. Administration of 7-nitroindazole showed dose-dependent neuroprotective effects against striatal dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) depletion 7 days after MPTP treatment. Behavioral testing showed that MPTP-treated mice exhibited motor deficits in the catalepsy test after 7 days, but 7-nitroindazole prevented the appearance of motor abnormalities in this test. The MPTP-treated mice exhibited the loss of tyrosine hydroxylase-containing dopaminergic neurons in mice after 1, 3 and 7 days, but 7-nitroindazole-treated mice showed a protective effect. GFAP (glial fibrillary acidic protein)-positive astrocytes were accumulated in the striatum 3 and 7 days and in the substantia nigra 1, 3 and 7 days after MPTP treatment. In contrast, 7-nitroindazole prevented a significant increase in the number of GFAP-positive astrocytes in the striatum and substantia nigra after MPTP treatment. The reactive astrocytes in the striatum and substantia nigra after MPTP treatment increased the production of S100beta protein, which is thought to promote neuronal damage, but 7-nitoindazole suppressed the expression of S100 beta protein. Activation of microglia, with an increase in staining intensity and morphological changes, was observed in the striatum and substantia nigra 1 and 3 days after MPTP treatment, but 7-nitroindazole prevented a significant increase in the number of isolectin B(4) positive microglia in the striatum and substantia nigra. On the other hand, nestin- immunoreactive cells were increased significantly in the striatum 3 and 7 days after MPTP treatment. 7-Nitroindazole treatment facilitated nestin expression in the striatum 7 days after MPTP treatment. Thus, nNOS inhibitor 7-nitroindazole protected dopaminergic neurons against MPTP neurotoxicity in mice and ameliorated neurological deficits. The results suggest that the neuroprotection is mediated though the modulation of glial activation, including the inhibition of S100beta synthesis and the prevention of microglial activation. These results suggest the therapeutic strategy targeted to glial modulation with 7-nitoindazole offers a great potential for the development of new neuroprotective therapies for Parkinson's disease.

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Publishing Authors By Initials

Y Watanabe,H Kato,T Araki,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Metabolic brain disease

VOLUME: 23

Page Numbers: 51-69

Journal Abbreviation:

ISSN: 0885-7490

DAY: 21

MONTH: 11

YEAR: 2007

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8610370

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.

AFFILIATION: Department of Neurobiology and Therapeutics, Graduate School and Faculty of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Metab Brain Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease Related Publications

• A new approach for evaluating renal function and its practical application.
• Analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy.
• Appearances of mediastinal and pulmonary hilar lymph nodes on thin-section CT: comparison with 5 mm slice thickness CT.
• Changes in the plasma diazepam concentration and its anticonvulsant effect after the discharge of a diazepam suppository from the rectum in rats.
• Cloning of a Novel Gene Encoding -1,3-Xylosidase from a Marine Bacterium, Vibrio sp. Strain XY-214, and Characterization of the Gene Product.
• Differential effects of psychological and physical stress on the sleep pattern in rats.
• Early pre-implantation lethality in mice carrying truncated mutation in the RNA polymerase 1-2 gene.
• Effect of high dose alpha-tocopherol acetate on the toxicity and tissue distribution of adriamycin (doxorubicin).
• Effect of high dose alpha-tocopherol and alpha-tocopherol acetate pretreatment on adriamycin (doxorubicin) induced toxicity and tissue distribution.
• Emerging occupational hazards among health care workers in the new millennium.
• Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.
• Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
• Gene trap mutagenesis in mice: new perspectives and tools in cancer research.
• Hepatectomy for hepatocellular carcinoma with indocyanine green excretory defect: a case report.
• Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin.
• IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance.
• Inhibitors of phospholipase promote apoptosis of human endothelial cells.
• Microwave spectrum of the H(2)DO(+) ion: Inversion-rotation transitions and inversion splitting.
• Monte carlo study of correction factors for the use of plastic phantoms in clinical electron dosimetry.
• On the isolation of mitochondria with high respiratory control from rat brain.
• Relationship between cumulative effects of smoking and memory CD4+ T lymphocyte subpopulations.
• State of binding subsites in Asp 101-modified lysozymes.
• Studies on the protein synthesis in silkglands. II. Effects of inhibitors on the transfer of radioactivity and role of lipid fraction in the protein synthesis.
• Studies on the protein synthesis in silkglands. III. Radioactive substances in cell debris.
• Survival case of Vibrio vulnificus infection with multiple endocrine neoplasia type I.
• The Influence of Hyperactivity of the Hypothalamic-pituitary-adrenal Axis and Hyperglycemia on the 5-HT2A Receptor-mediated Wet-dog Shake Responses in Rats.
• The effects of atropine on changes in the sleep patterns induced by psychological stress in rats.
• The impact factor and INDUSTRIAL HEALTH.
• Twenty Years of Publishing Trends and Citation Indexing at INDUSTRIAL HEALTH, 1987-2006.
• [A case of human herpesvirus 6 encephalopathy with biphasic seizures, showing normal diffusion image on MRI before the second epileptic exacerbation]